Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
George Elston currently holds 25,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Elston has been a net buyer of EYPT stock. They have purchased $40.3K and sold $0 worth of shares.
George Elston's most recent insider trade was on Dec 19, 2025, when they sold 5,000 shares at $0.00 per share.
George Elston serves as Executive at EyePoint Pharmaceuticals, Inc. (EYPT). They have executed 35 insider transactions totaling $40.3K over their tenure at the company.
George Elston holds the position of Executive at EyePoint Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
George Elston has shown a buying trading pattern, with $40.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by George Elston was on Jan 6, 2024, when they sold $100.2K worth of EYPT shares. This transaction involved 4,911 shares at $20.40 per share.
George Elston currently owns 25,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of George Elston's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. George Elston has 35 Form 4 filings on record as an insider at EyePoint Pharmaceuticals, Inc..
Set alerts for George Elston and 40,000+ other insiders.